When to measure Lp(a)?
🔶Family hx of premature ASCVD
🔶Premature ASCVD
🔶LDL >190, suspected FH
🔶Very high ASCVD risk to better define benefit from PCSK9i
6/ CV Risk Assessment
Guidelines recommend use of pooled cohort equations (PCE) for 10-year ASCVD risk
🛑Can under- and over-estimate risk in some populations➡️consider risk-enhancing factors
🛑May use CAC score in risk assessment & treatment decision
Follow this #CardsNarratives 🧵 on Valvular Heart Disease in Women
2/ We’ll cover these 2 questions:
❓What are the disparities in valvular heart disease in women?
❓What changes need to be implemented to improve the care of women with valvular heart disease?
3/ I feel comfortable openly discussing or asking others about factors that make them different from myself like race, religion, ethnicity, gender, sexual orientation, immigration status, etc
Follow this #CardsNarratives🧵on the discussion about gender equity & women in Cardiology/Electrophysiology (EP)
2/ We'll cover these 3 questions:
🔸Why should we promote gender diversity in Cardiology/EP?
🔸How do we address barriers for women in Cardiology/EP?
🔸What are some opportunities for EP in private practice?
3/ I feel comfortable openly discussing or asking others about factors that make them different from myself like race, religion, ethnicity, gender, sexual orientation, immigration status, etc
1/ #ASPC2021 talk for Honorary Fellowship Award by @NMHheartdoc on New Kind of Prevention – Reducing CV Health Disparities at Community and Individual Level